Light adjustable lenses offer stability of refraction

Article

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Arturo Chayet from the Codet Vision Institute, Mexico and colleagues from the US conducted a prospective study implanting LALs that would purposely result in myopic errors of up to -1.5 D in 14 eyes of 14 patients. The LALs were treated with a spatial intensity profile to induce a targeted myopic refractive change. The LALs were treated again once the desired correction was achieved in order to 'lock in' the lens power.

Thirteen of the 14 eyes attained 0.25 D of the target refraction one day following the 'lock-in' and 100% of eyes achieved target refraction adjustment within 0.5 D during the 9-month follow-up period. No changes were recorded in manifest spherical refraction between the first day post 'lock-in' and the end of follow-up.

The researchers noted that the mean rate of refractive change was 0.006 D per month, making this treatment approach approximately six times more stable than laser corneal refractive procedures.

Click here to read the full abstract.

Recent Videos
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.